Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: OPDC-34712 plus stimulant therapy; Drug: Placebo plus stimulant therapy
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Not yet recruiting - verified February 2010